Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-12-17 5:08 pm Purchase | 2021-12-16 | 13D | Janux Therapeutics, Inc. JANX | ORBIMED ADVISORS LLC | 2,649,464 6.400% | 2,649,464 (New Position) | Filing History |
| 2021-12-14 5:29 pm Purchase | 2021-12-10 | 13D | RESTORBIO INC TORC | ORBIMED ADVISORS LLC | 6,147,599 15.700% | 214,285 (+3.61%) | Filing History |
| 2021-12-06 4:25 pm Sale | 2021-12-02 | 13G | CTI BioPharma Corp. CTIC | ORBIMED ADVISORS LLC | 4,024,821 4.000% | -5,495,179 (-57.72%) | Filing History |
| 2021-11-18 5:10 pm Unchanged | 2021-11-15 | 13D | Theseus Pharmaceuticals, Inc. THRX | ORBIMED ADVISORS LLC | 16,838,668 43.500% | 0 (Unchanged) | Filing History |
| 2021-11-18 4:56 pm Sale | 2021-11-12 | 13D | Acutus Medical, Inc. AFIB | ORBIMED ADVISORS LLC | 2,648,386 9.500% | -4,233,567 (-61.52%) | Filing History |
| 2021-11-12 5:05 pm Purchase | 2021-11-10 | 13D | Alpine Immune Sciences, Inc. ALPN | ORBIMED ADVISORS LLC | 4,226,843 14.400% | 1,010,637 (+31.42%) | Filing History |
| 2021-11-09 5:30 pm Purchase | 2021-11-04 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 18,071,547 18.400% | 5,357,143 (+42.13%) | Filing History |
| 2021-11-05 4:26 pm Purchase | 2021-11-05 | 13D | Sierra Oncology, Inc. SRRA | ORBIMED ADVISORS LLC | 3,044,753 18.100% | 3,033,090 (+26006.64%) | Filing History |
| 2021-11-03 3:03 pm Unchanged | 2021-11-02 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 6,943,654 14.900% | 0 (Unchanged) | Filing History |
| 2021-11-02 5:01 pm Sale | 2021-11-01 | 13D | Repare Therapeutics Inc. RPTX | ORBIMED ADVISORS LLC | 3,177,041 7.700% | -99,284 (-3.03%) | Filing History |
| 2021-10-19 5:23 pm Purchase | 2021-10-12 | 13D | Theseus Pharmaceuticals, Inc. THRX | ORBIMED ADVISORS LLC | 16,838,668 44.900% | 16,838,668 (New Position) | Filing History |
| 2021-10-14 5:00 pm Sale | 2021-10-12 | 13G | KALA BIO, Inc. KALA | ORBIMED ADVISORS LLC | 0 0.000% | -188,568 (Position Closed) | Filing History |
| 2021-09-29 4:31 pm Purchase | 2021-09-27 | 13D | Synlogic, Inc. SYBX | ORBIMED ADVISORS LLC | 402,000 9.000% | 155,556 (+63.12%) | Filing History |
| 2021-09-22 5:21 pm Sale | 2021-09-20 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 6,943,654 16.400% | -1,109,644 (-13.78%) | Filing History |
| 2021-09-03 4:47 pm Sale | 2021-08-26 | 13D | Whitehawk Therapeutics Inc WHWK | ORBIMED ADVISORS LLC | 346,262 1.700% | -1 (-0.00%) | Filing |
| 2021-09-03 4:37 pm Sale | 2021-08-30 | 13D | BELLUS Health Inc. BLU | ORBIMED ADVISORS LLC | 2,954,800 3.800% | -1,000,000 (-25.29%) | Filing History |
| 2021-08-31 4:52 pm Purchase | 2021-08-23 | 13D | Acutus Medical, Inc. AFIB | ORBIMED ADVISORS LLC | 6,881,953 7.700% | 1,071,428 (+18.44%) | Filing History |
| 2021-08-16 4:45 pm Unchanged | 2021-08-12 | 13D | Ikena Oncology, Inc. IKNA | ORBIMED ADVISORS LLC | 161,407 5.400% | 0 (Unchanged) | Filing History |
| 2021-08-12 4:17 pm Sale | 2021-08-10 | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 2,212,571 5.600% | -254,721 (-10.32%) | Filing History |
| 2021-08-04 5:21 pm Unchanged | 2021-08-02 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 8,053,298 19.000% | 0 (Unchanged) | Filing History |